ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 0.79% of CNSP shares are held by financial institutions. PRIME CAPITAL INVESTMENT ADVISORS, LLC is the top corporate investor, holding 10.73K shares valued at $2.00K. A 0.03% stake in CNS Pharmaceuticals, Inc. is owned by the company. GRADIENT INVESTMENTS LLC owns 200 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the CNSP insiders holding of 1.04% of the stake in company, CLIMACO JOHN M, Chief Executive Officer, holds the largest shares of 215.68K. PRIEBE WALDEMAR, 10 percent owner, is the second largest CNSP insider with ownership of 156.81K shares. DOWNS CHRISTOPHER, Chief Financial Officer, stands third with possession of 103.44K shares of that stake.